Y-Intercept (HK)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.8M Buy
148,345
+137,794
+1,306% +$38.1M 0.65% 7
2026
Q1
$3.12M Buy
+10,551
New +$3.13M 0.06% 513
2025
Q4
Sell
-6,663
Closed -$1.8M 1606
2025
Q3
$1.8M Sell
6,663
-7,321
-52% -$1.99M 0.04% 673
2025
Q2
$3.85M Buy
+13,984
New +$3.8M 0.09% 308
2024
Q3
Sell
-17,050
Closed -$3.35M 1369
2024
Q2
$3.35M Buy
17,050
+8,616
+102% +$1.78M 0.18% 119
2024
Q1
$1.82M Buy
+8,434
New +$1.77M 0.14% 189
2023
Q4
Sell
-8,910
Closed -$1.78M 1276
2023
Q3
$1.78M Buy
+8,910
New +$1.77M 0.17% 165
2023
Q2
Sell
-5,391
Closed -$1.03M 1325
2023
Q1
$1.03M Buy
+5,391
New +$975K 0.12% 245
2022
Q4
Sell
-3,251
Closed -$576K 1040
2022
Q3
$576K Buy
+3,251
New +$642K 0.06% 480
2022
Q2
Sell
-3,271
Closed -$778K 899
2022
Q1
$778K Buy
+3,271
New +$768K 0.18% 162
2021
Q3
Sell
-2,772
Closed -$590K 681
2021
Q2
$590K Buy
+2,772
New +$585K 0.15% 218

Other funds holding CME

Y-Intercept (HK)'s CME Position: Q2 2026 in Review

Y-Intercept (HK) increased its CME Group (CME) stake by 1,306% in Q2 2026, buying an estimated $38.1M and bringing the position to 148,345 shares worth $32.8M. The position accounts for 0.65% of the portfolio, ranked #7.

Y-Intercept (HK) first reported a position in CME in Q2 2021 and has held it in 11 quarters since. 322 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Y-Intercept (HK) held 148,345 shares of CME Group worth $32.8M as of Q2 2026.
  • Y-Intercept (HK) bought 137,794 CME Group shares in Q2 2026, an estimated $38.1M.
  • CME Group made up 0.65% of Y-Intercept (HK)'s portfolio in Q2 2026, its #7 holding.
  • Y-Intercept (HK) first reported a position in CME Group in Q2 2021 and has held it in 11 quarters since.
  • 322 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.